Yalcin, A. D. Et Al. 2013. Effects of omalizumab on eosinophil cationic peptid, 25-hydroxyvitamin-D, IL1 beta, and SCD200 in a cases of samter's syndrome: 36 months follow-up. Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , (Taipei, Taiwan), 26.

Yalcin, A. D., Ucar, S., GÜMÜŞLÜ, S., & Strauss, L. G., (2013). Effects of omalizumab on eosinophil cationic peptid, 25-hydroxyvitamin-D, IL1 beta, and SCD200 in a cases of samter's syndrome: 36 months follow-up . Asia Pacific Congress of Allergy, Asthma and Clinical Immunology (pp.26). Taipei, Taiwan

Yalcin, A. Et Al. "Effects of omalizumab on eosinophil cationic peptid, 25-hydroxyvitamin-D, IL1 beta, and SCD200 in a cases of samter's syndrome: 36 months follow-up," Asia Pacific Congress of Allergy, Asthma and Clinical Immunology, Taipei, Taiwan, 2013

Yalcin, A. D. Et Al. "Effects of omalizumab on eosinophil cationic peptid, 25-hydroxyvitamin-D, IL1 beta, and SCD200 in a cases of samter's syndrome: 36 months follow-up." Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , Taipei, Taiwan, pp.26, 2013

Yalcin, A. D. Et Al. (2013) . "Effects of omalizumab on eosinophil cationic peptid, 25-hydroxyvitamin-D, IL1 beta, and SCD200 in a cases of samter's syndrome: 36 months follow-up." Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , Taipei, Taiwan, p.26.

@conferencepaper{conferencepaper, author={A. D. Yalcin Et Al. }, title={Effects of omalizumab on eosinophil cationic peptid, 25-hydroxyvitamin-D, IL1 beta, and SCD200 in a cases of samter's syndrome: 36 months follow-up}, congress name={Asia Pacific Congress of Allergy, Asthma and Clinical Immunology}, city={Taipei}, country={Taiwan}, year={2013}, pages={26} }